Background: Empagliflozin reduces the risk of hospitalization for heart failure in patients
with type 2 diabetes and cardiovascular disease. We sought to elucidate the effect of …

Aim We carried out a randomized controlled trial using ipragliflozin. We analyzed changes in
diastolic function using echocardiography in patients with type 2 diabetes and heart failure …

Background Immune-related adverse events (irAEs) in patients treated with immune check
inhibitors are associated with favourable response rate and survivals in multiple cancers, …

Background The proportion of adult patients with return of spontaneous circulation (ROSC)
following out-of-hospital cardiac arrest (OHCA) remains unchanged since 2012. A better …

Aim: Serum levels of cholesterol absorption and synthesis markers have been associated
with cardiovascular risk in the United States and European countries. In this study, we …

This prospective observational single-center cohort study aimed to determine an association
between cerebrovascular autoregulation (CVAR) and outcomes in hypoxic-ischemic brain …

Background and Objective The relative effectiveness of initial non‐invasive respiratory
strategies for acute respiratory failure using continuous positive airway pressure (CPAP) or high‐…

Aim: Serum levels of cholesterol absorption and synthesis markers are known to be
associated with cardiovascular risk. Individuals with reduced kidney function or chronic kidney …

Aim: Risk of cardiovascular disease is increased in patients with diabetes mellitus (DM).
Cholesterol metabolism (hepatic synthesis and intestinal absorption) is known to be associated …

Aim: Serum levels of cholesterol absorption and synthesis markers are known to be associated
with cardiovascular risk. Familial hypercholesterolemia (FH) is a well-known inherited …